Jones Financial Companies
PCVX icon

Jones Financial Companies’s Vaxcyte PCVX Stock Holding History

Jones Financial Companies’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Buy
6,068
+2,497
+70% +$136K ﹤0.01% 2369
2026
Q1 		$190K Buy
3,571
+3,461
+3,146% +$188K ﹤0.01% 2421
2025
Q4 		$5.08K Hold
110
– – ﹤0.01% 3492
2025
Q3 		$3.74K Sell
110
-5
-4% -$166 ﹤0.01% 3472
2025
Q2 		$3.75K Buy
115
+36
+46% +$1.18K ﹤0.01% 3237
2025
Q1 		$5.49K Sell
79
-67
-46% -$5.36K ﹤0.01% 2925
2024
Q4 		$12K Buy
146
+78
+115% +$7.75K ﹤0.01% 2453
2024
Q3 		$7.69K Buy
+68
New +$6.13K ﹤0.01% 2309

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jones Financial Companies's PCVX Position: Q2 2026 in Review

Jones Financial Companies increased its Vaxcyte (PCVX) stake by 70% in Q2 2026, buying an estimated $136K and bringing the position to 6,068 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Jones Financial Companies first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Jones Financial Companies held 6,068 shares of Vaxcyte worth $343K as of Q2 2026.
  • Jones Financial Companies bought 2,497 Vaxcyte shares in Q2 2026, an estimated $136K.
  • Vaxcyte made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2369 holding.
  • Jones Financial Companies first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.